Literature DB >> 2904706

Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.

R Gerzer1, B Karrenbrock, W Siess, J M Heim.   

Abstract

We have directly compared the effects of the nitrates isosorbide-5-mononitrate, nitroglycerin and isosorbide dinitrate and of the nitric oxide-containing sodium nitroprusside and 3-morpholino-sydnonimine (SIN 1) as well as of the bioinactive precursor of SIN 1, molsidomine, on platelet activating factor-induced platelet aggregation and activation of soluble guanylate cyclase. The effects of these agents on the aggregation and on soluble guanylate cyclase activity of human platelets were closely correlated. Whereas nitroprusside and SIN 1 were very potent inhibitors of aggregation and activators of soluble guanylate cyclase in micromolar concentrations, the other drugs were effective only at millimolar concentrations. Preincubation of platelets with cysteine did not or only slightly increase the ability of isosorbide-5'-mononitrate and isosorbide dinitrate to inhibit aggregation, but a clear increase was observed after preincubation with nitroglycerin. These data support the concept that cyclic GMP is the mediator of nitric oxide-induced inhibition of platelet aggregation and indicate that nitrates cannot directly inhibit aggregation or be converted to nitric oxide-containing agents by a specific mechanism in platelets. The data also suggest that SIN 1 and nitroprusside, but not or only to a certain degree the nitrates, can be considered as exogenous endothelium-derived relaxing factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904706     DOI: 10.1016/0049-3848(88)90036-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  13 in total

1.  Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.

Authors:  R J Gryglewski; A Zembowicz; D Salvemini; G W Taylor; J R Vane
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.

Authors:  H Sinzinger; F Rauscha; J O'Grady; P Fitscha
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.

Authors:  B Karrenbrock; J M Heim; R Gerzer
Journal:  Klin Wochenschr       Date:  1990-02-15

4.  Influence of authentic nitric oxide on basal cytosolic [Ca2+] and Ca2+ release from internal stores in human platelets.

Authors:  K H Le Quan Sang; F Lantoine; M A Devynck
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Synergistic inhibition of thrombin-induced platelet aggregation by the novel nitric oxide-donor GEA 3175 and adenosine.

Authors:  M Grenegård; M C Gustafsson; R G Andersson; T Bengtsson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.

Authors:  G Archipoff; A Beretz; K Bartha; C Brisson; C de la Salle; C Froget-Léon; C Klein-Soyer; J P Cazenave
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.

Authors:  P M Bath
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Chlorpromazine inhibits nitric oxide-mediated increase in intracellular cGMP in a mouse teratocarcinoma cell line.

Authors:  M Fratelli; R Delgado; M Zinetti; G Galli; Y Rolland; P Ghezzi
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

9.  Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.

Authors:  N H Wallén; P T Larsson; A Bröijersén; A Andersson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

10.  Potentiation of the hyporeactivity induced by in vivo endothelial injury in the rat carotid artery by chronic treatment with fish oil.

Authors:  G A Joly; V B Schini; H Hughes; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.